Profitability
Weight: 25%
C-
50
- 5yr Avg ROIC 5.5%
- Operating Margin Trend +0.86 pp/yr
BSX
Boston Scientific Corporation
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
D+
44
- 5yr Avg ROE 6.7%
- 5yr Share-Count CAGR 1.0%
Growth Quality
Weight: 25%
A+
95
- 5yr Revenue CAGR 14.0%
- 5yr EPS CAGR 29.6%
- Revenue-Growth Years (5) 5/5
Cash Generation
Weight: 20%
A-
85
- 5yr FCF Margin 12.9%
- 5yr FCF/NI Conversion 1.27x
Balance Sheet
Weight: 10%
B+
78
- Net Debt / EBITDA 2.03x
- Interest Coverage (EBIT/Int) 10.70x
- Altman Z-Score 3.33
Stability
Weight: 5%
C-
50
- EPS Volatility (σ/μ) 0.88
- Piotroski F-Score 7
- Negative-Revenue Years (5) 0/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.5 of 6 gurus held; 1 added; 4 trimmed; 1 full exit.
- Holders
- 5 -1
- Avg Δ position
- -8.2%
- New buys
- 0
- Full exits
- 1
- Halvorsen sold -100%
- Greenblatt increased +203%
- Cooperman decreased -99%